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SLE: Systemic lupus erythematosus 
TNF: Tumour necrosis factor 
PD: Parkinson’s disease 
GET: Graded exercise therapy 
CBT: Cognitive behavioural therapy 
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Abstract 
Objective 
Fatigue is prominent across many long term physical health conditions. This scoping review 
aimed to map the fatigue intervention literature, to ascertain if certain interventions may be 
effective across conditions, and if novel interventions tested in specific long term conditions 
may be promising for other conditions.  
 
Methods 
Scoping review methodological frameworks were used. Electronic bibliographic databases 
were searched (inception to November 2016) for systematic reviews of fatigue interventions 
in long term conditions. Inclusion criteria were: long term physical health condition; review 
focus on fatigue management; objective and systematic review process; primary review 
outcome is fatigue. Articles focussing on surgical interventions or treatments thought to 
trigger fatigue were excluded. A narrative synthesis was performed.  
 
Results 
Of 115 full texts screened, 52 reviews were included. Interventions were categorised as 
pharmacological and non-pharmacological (exercise, psychological/behavioural and 
complementary medicine). Pharmacological interventions did not consistently demonstrate 
benefit, except for anti-TNFs and methylphenidate which may be effective at reducing 
fatigue. Non-pharmacological interventions such as graded exercise and fatigue-specific 
psychological interventions may be effective, but heterogeneous intervention components 
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limit conclusions. ‘Complementary medicine’ interventions (e.g. Chinese herbal medicines) 
showed promise, but the possibility of publication bias must be considered.  
Conclusions 
Further research is necessary to inform clinical practice.  The reported effectiveness of some 
interventions across inflammatory health conditions, such as anti-TNFs, aerobic exercise, and 
psychologically based approaches such as CBT, highlights a potential transdiagnostic avenue 
for fatigue management. More novel strategies that may be worth exploring include 
expressive writing and mindfulness, although the mechanisms for these in relation to fatigue 
are unclear. More work is needed to identify transdiagnostic mechanisms of fatigue and to 
design interventions based on these.  
 
Introduction 
Fatigue can be described as a lack of energy, feeling of exhaustion or overwhelming sense of 
tiredness (either physical or mental), that is not relieved by rest and  is a common and 
debilitating symptom in many long-term, physical health conditions (LTCs) [1-4]. LTCs are, 
defined as a physical health conditions that require on-going management over a period of 
years [5], for example liver disease, HIV, rheumatoid arthritis (RA) and multiple sclerosis 
(MS)[6,7]. Recently there has been a move towards conceptualising fatigue as having 
commonalities across conditions and identifying person-specific (rather than solely illness-
specific) factors across domains (i.e. behavioural, cognitive, physiological, social and 
emotional) [8,9]  in a more transdiagnostic approach to management.  
 
A recent scoping review of systematic reviews investigated interventions for fatigue in adults 
with advanced progressive illness. Authors concluded there is a lack of robust evidence 
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available in support of intervention effectiveness [10]. However, only Cochrane reviews were 
searched, and only six conditions included under ‘advanced progressive illness’ (cancer, 
motor neuron disease, chronic obstructive pulmonary disease, cystic fibrosis, HIV/AIDS and 
MS). The search for relevant articles is likely to have been limited and insights missed from 
other conditions where fatigue is prominent, e.g. chronic fatigue syndrome and rheumatoid 
arthritis [11,12]. Additional systematic reviews have also been conducted since, so an 
updated and more inclusive scoping review may provide more in-depth insights of clinical 
relevance. 
 
Scoping reviews are a relatively new approach to collating health research evidence. They 
aim to map the existing literature in a field of interest and can be of particular use for topics 
that have not been extensively reviewed or are complex in nature [13]. They are becoming 
increasingly popular due to their ability to map key concepts, sources of evidence and types 
of evidence underpinning a research area [13]. They are valuable for comparing reviews of 
fatigue interventions across health conditions, where different study designs and interventions 
may be of interest [14]. 
 
The aims of this scoping review are: 
1. Map the range of reviews conducted on interventions used to treat, reduce or manage 
fatigue in LTCs, defined as a long-term, physical health condition  
2. Identify commonalities between interventions used across conditions and whether 
these are effective, which may highlight transdiagnostic aspects of fatigue 
management. 
3. Identify novel interventions trialled in any single condition, which may be promising 
in the treatment of fatigue in other health conditions. 
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Methods 
Protocol 
A protocol was developed prior to conducting this review, based upon detailed methodology 
outlined in the Joanna Briggs Institute (JBI) Reviewers’ Manual [15] and the framework 
proposed by Arksey & Malley [14] and updated by Levac et al. [16]. This framework consists 
of six stages: (1) identifying the research question, (2) identifying relevant studies, (3) 
selecting studies, (4) charting the data, (5) collating, summarising and reporting the results, 
and (6) consultation. The scoping review process is an iterative one, particularly during the 
study selection phase [16]. During full text screening, the inclusion and exclusion criteria 
were refined for clarity and specificity to the review’s objectives after discussion amongst the 
research team. In line with the published guidelines for scoping reviews [15] and the aims of 
mapping rather than rating the existing literature, we did not conduct quality assessment.  
 
Stage 1: Identifying the research question 
The specific questions guiding this scoping review were: i) What fatigue interventions are 
used to treat, reduce or manage fatigue in LTCs, defined as a long-term, physical health 
condition?? ii) What interventions are commonly used across conditions, and which are 
consistently reported as effective? iii) Which novel interventions from individual LTCs may 
be promising?  
 
Stage 2: Identifying relevant studies 
Search strategy 
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Comprehensive and systematic electronic searches were designed, refined and conducted in 
consultation with an information specialist, combining MeSH terms and keywords relating to 
‘fatigue intervention’ and ‘review’ (full search strategies can be found in Appendix A). 
Search strategies were designed to maximise comprehensiveness and sensitivity in the initial 
search [15],  and then increase specificity in the later screening. Therefore, names of 
individual conditions, as well as the term ‘long term condition’, were not specified in the 
initial search criteria. This minimised the risk of missing potentially relevant research, either 
reviews in less well-known LTCs or those in individual conditions not specifying ‘long term 
condition’ as a key word for searches. 
 
The following databases were searched from their inception to November week 1, 2016: 
Cochrane Database of Systematic Reviews, PsycINFO; EMBASE; OvidMEDLINE(R); 
OvidMEDLINE(R) in process and other non-indexed citations; CINAHL; Web of Science; 
LILACS; PEDro. OpenGrey and Google Scholar were used to search for grey literature, and 
experts in the field were contacted. Reference lists and citations of included reviews were 
hand-searched. Only articles in the English language were considered for inclusion.  
 
Stage 3: Selecting studies 
Eligibility criteria 
Inclusion and exclusion criteria can be found in Table 1. It is recommended that eligibility 
criteria are defined through an iterative process [15]. Therefore, we refined the inclusion and 
exclusion criteria during the screening process, in collaboration with an information 
specialist, to ensure our research aims were accurately met: 
1. Some reviews were found to group healthy and LTC populations together during analysis 
and not clearly describe the different populations, so we refined our initial inclusion criterion 
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of ‘long term physical health conditions’ to ‘solely long term physical health conditions, 
clearly described’. 
2. Initially our focus was interventions with fatigue as the primary outcome. It became clear 
that most reviews included studies which had measured fatigue as a primary or secondary 
outcome. To maintain breadth across the field of research, we shifted the focus to defining 
the primary outcome of the systematic review. 
3. In addition to point 2, we specified that fatigue management was the focus of review as 
some reviews include measures of fatigue but focus on reviewing ways of assessing fatigue 
or documenting fatigue as a side effect of a treatment. 
4.. The exclusion criterion ‘population undergoing surgical intervention’ was added during 
the second screening phase, as surgery was deemed to be a permanent, condition specific 
procedure (where fatigue was not the primary outcome), not of relevance to our aims of 
identifying transdiagnostic interventions. 
5.. Similarly, fatigue caused by treatments or medications for specific conditions has a 
physiological basis that was beyond the scope of this review, thus an exclusion criterion was 
defined during the second phase of screening. These iterations were defined after discussion 
amongst the research team. 
 
 
 
 
 
 
 
Table 1. Inclusion and exclusion criteria 
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Types of studies 
We initially searched for reviews of fatigue interventions, including (but not limited to) 
systematic reviews, meta-analyses, narrative synthesis, literature reviews and scoping 
reviews, to ensure comprehensive identification of potentially relevant articles. Inclusion 
criteria were employed to select reviews which had systematically searched for papers, to 
identify the highest order of evidence. We defined ‘systematically conducted’ as employing a 
systematic and objective search strategy, using inclusion criteria and searching two or more 
databases. 
 
 
 Inclusion  Exclusion 
Solely long term physical health condition, 
clearly described. 
Population undergoing surgical 
intervention. 
Fatigue management is a main focus of 
review. 
Focus on a population undergoing treatment 
causing fatigue. 
Objective and systematic review process; 2+ 
databases searched, screening 
process/criteria for inclusion. 
Article is a previous version of a more 
recent, updated review. 
Primary outcome of review is fatigue (i.e. 
studies included target or evaluate fatigue). 
Article not in English. 
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Population 
The population of interest was ‘long term health condition’, defined as a long-term, physical 
health problem. 
 
Concept 
Interventions could include (but were not limited to) pharmacological, psychological, 
educational, behavioural and exercise methods. Initially, the focus was interventions with a 
primary aim of treating fatigue but it became clear that relevant reviews often included 
studies which had measured fatigue as both a primary or secondary outcome. Rather than 
specifying the outcomes of individual studies, we specified that a primary outcome and focus 
of the review had to be fatigue.  
 
 Interventions for fatigue due to treatment, as opposed to the health condition, were beyond 
the scope of this review. As cancer treatment is known to be associated with fatigue after 
treatment and reviews did not typically distinguish between disease-related and treatment-
related fatigue, cancer-related fatigue was not included in analyses.  
 
Context 
No limitations were set regarding the context of reviews. 
 
Screening 
Titles and abstracts of identified articles were screened by KH. Full texts of potentially 
relevant articles were then screened by KH against the eligibility criteria, 10% of which were 
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quality checked/screened by ST. Any articles where inclusion was unclear were cross-
checked and discussed between KH and ST. 
In the absence of full texts of abstracts or review protocols, authors were emailed to ask for 
the full review article. In the case of abstracts, if the author did not reply but enough 
information was included for a decision to be made using the eligibility criteria, abstracts 
were evaluated for inclusion. 
 
Stage 4: Charting the data 
Data extraction 
Data were extracted using two tables; one for review characteristics and the other for fatigue 
related findings of each review (see supplementary tables for further details). Data extraction 
was conducted by KH and RS, with half of full texts assigned to each extractor. Double 
extraction occurred for the first ten articles. Extraction was discussed and any necessary 
amendments to extraction table headings were made to maximise clarity and accuracy.  
 
Stage 5: Collating, summarising and reporting the data. 
Data synthesis  
A descriptive numerical summary and tabulation of findings was conducted. Findings were 
presented in a narrative synthesis, grouped by type of intervention, to identify fatigue 
interventions common (and beneficial) across LTCs, as well as interventions only 
implemented in certain physical health conditions. 
 
Stage 6: Consultation. 
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Experts in the field of fatigue and individual health conditions were consulted during protocol 
preparation, to help establish inclusion criteria and identify grey literature. Findings were also 
discussed.  
Results 
Search and selection of included reviews 
The database search returned 5,232 records, of which 97 were deemed potentially relevant 
after removing duplicates and title/abstract screening. Searching additional sources (e.g. 
references from experts and reference/citation lists) identified 18 further articles of potential 
relevance. In all, 115 articles were assessed for eligibility.   
 
Of the four authors emailed about conference abstracts, none responded. For protocols, three 
authors (for four of eight protocols) replied, indicating that reviews were ongoing [17-20]. 
 
After full text screening, 51 articles were retained for inclusion in the scoping review, 
encompassing 52 reviews (Fig 1). Branas et al. [21] included both a scoping and a systematic 
review in one article so both were included. 
 
 
Fig 1. Flow diagram detailing the inclusion/exclusion process. 
 
Included reviews 
An overview of the included reviews can be seen in Table 2. Review characteristics are 
outlined in more detail in supplementary information (S1 Table), as are review findings (S2-
S5 Tables). 
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Table 2. Overview of reviews 
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Review 
characteristics 
(N=52) 
 Count 
(%) 
Review type Narrative synthesis 18 (35%) 
Meta-analysis 24 (46%) 
Scoping review 3 (6%) 
Systematic overview (including specific section on fatigue 
interventions) 
4 (7%) 
Conference proceedings - abstract 3 (6%) 
Year of 
publication 
No date 2 (4%) 
Pre-2005 2 (4%) 
2006-2011 15 (29%) 
2012-2015 23 (44%) 
2016 8 (15%) 
2017 2 (4%) 
Health 
condition 
studied 
Multiple Sclerosis 18 (34%) 
Chronic Fatigue Syndrome 8 (15%) 
‘Mixed’ clinical populations  6 (11%) 
Parkinson’s Disease 3 (6%) 
Systemic Lupus Erythematosus 3 (6%) 
Rheumatoid Arthritis  3 (6%) 
End Stage Kidney Disease 2 (4%) 
Inflammatory Bowel Disease 1 (2%) 
Sarcoidosis 1 (2%) 
Traumatic Brain Injury 1 (2%) 
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The majority of included reviews have been published or conducted in the past five years (n= 
33). Twenty two reviews only included randomised controlled trials (RCTs), whereas other 
reviews included other study designs, such as pretest-posttest, open-label, pilot and crossover 
trials.  
 
Reviews included a wide range of research articles, ranging from zero (Adams et al. [22] who 
did not identify any Chinese medicine chronic fatigue syndrome (CFS) intervention papers 
fulfilling their inclusion criteria) to 45 [23,24]. Reporting of total participant numbers was 
variable; some reviews omitted this information whilst others provided a range and/or overall 
total. Of the 38 reviews that stated the total, this ranged from 36 to 14,628 participants. The 
HIV 1 (2%) 
Heart disease 1 (2%) 
Fibromyalgia 1 (2%) 
Sjogren’s Syndrome 1 (2%) 
Peripheral neuropathy 1 (2%) 
Post-stroke 1 (2%) 
Review focus Pharmacological interventions 
Non-pharmacological interventions 
Mixture/not specified 
10 (19%) 
28 (54%) 
14 (27%) 
Review size Number of studies included in reviews  
- Minimum to maximum 
- Average 
 
0 – 45 
17 
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next largest samples were 4,765, 4,696 and 2,882, with most reviews reporting on fewer than 
1,500 participants. The larger participant samples tended to be from reviews including a 
variety of study designs, investigating several health conditions or reviewing 
pharmacological interventions.  
 
In line with the aims of this review, findings have been grouped by intervention type; 
pharmacological and non-pharmacological interventions. Non-pharmacological interventions 
have been further divided into three broad categories; ‘exercise’, ‘psychological/behavioural’ 
and ‘complementary medicine’ (Table 3). The descriptors provided for the various 
interventions grouped under these broad categories are listed in Table 3, which also presents 
review categories in relation to specified LTCs.  
 
For each intervention type, we first describe the type of interventions used and for which 
conditions as per aim 1. In line with aim 2 we then describe effectiveness findings, 
highlighting if these have been shown to be effective across more than one condition (i.e. 
whether they have potential for transdiagnostic fatigue management). The final section 
explores novel interventions trialled in any single condition, which may be promising in the 
treatment of fatigue in other health conditions. 
 
Multiple reviews in the same health condition often included the same intervention studies, so 
findings are primarily presented in relation to health conditions as a whole, as opposed to 
each review individually.  
 
Table 3. Overview of fatigue interventions in the included reviews
17 
 
 
 
 
 
 
 
 
 
Intervention 
 
(including common/relevant 
subtypes) 
 
Health condition 
CFS RA SLE PD TBI IBD Sarcoidosis Peripheral 
neuropathy 
Coronary 
heart 
disease 
HIV ESKD Post-
stroke 
Fibro-
myalgia 
Sjorgen’s 
Syndrome 
MS Mixed 
Pharmacological 1 2 1 3 1 1 1 1  1  1  1 8 2 
Exercise 4 1 3 3 1 1 1  1  1 1 1  9 2 
Psychological/behavioural 
 
4 1 3 1 1 1    1 1 1   8 4 (overlap) 
1. CBT based x x x x x     x x x   x  
2. Education  x x  x       x   x  
3. Management (various)  x x   x     x    x  
4. Relaxation   x       x       
5. Counselling   x              
18 
 
6. Mindfulness   x          x   x x (specific) 
7. Expressive writing  x x              
8. Energy conservation  x             x  
9. Solution focussed therapy      x           
10. Guided imagery                x (specific) 
Complementary medicine 
 
2 1 2 1 1 1     1 1   3 2 (overlap) 
1. Acupuncture (or similar) x  x        x x     
2. Herbal medicine x x          x     
3. Diet  x x              
4. Supplements  x x   x           
5. Phototherapy   x              
6. Pulsed electromagnetic therapy               x  
7. Cooling               x  
8. Electroenc. Biofeedback     x            
9. Cranial electro. stimulation     x            
10. Blue light     x            
11. Reflexology  x               
12. Japanese massage    x             
 
Note: the numbers given show the number of reviews in each condition that have included interventions classed as pharmacological, exercise, 
psychological/behavioural and complementary medicine, respectively. (x) denotes more specifically which types of interventions, under the 
psychological/behavioural and complementary medicine headings, have been investigated in each health condition. Where possible subgroups were provided, 
however, descriptions of interventions in the exercise category were extremely variable so creating meaningful and accurate subgroups was not possible. Sub-
headings are based upon the labels given in reviews.  
(CFS; Chronic fatigue syndrome, RA; Rheumatoid arthritis, SLE;  Systemic lupus erythematosus,  PD; Parkinson’s disease,  TBI;  Traumatic brain 
injury,  IBD;  Inflammatory bowel disease,  HIV;  Human immunodeficiency virus,  ESKD; End stage kidney disease, MS; Multiple sclerosis) 
 
19 
 
 
 
Pharmacological interventions 
Pharmacological interventions were considered in 24 reviews, of which 10 focussed 
specifically on pharmacological agents (see S2 Table). 
 
The most common pharmacological agents in multiple conditions were: 
• Psychostimulants; methylphenidate and modafinil (sarcoidosis, Parkinson’s disease 
(PD), traumatic brain injury (TBI), HIV and MS). 
• Anti-TNF biologic agents, such as adalimumab and infliximab (RA, inflammatory 
bowel disease (IBD), sarcoidosis and Sjogren’s syndrome). 
• Dehydroepiandrosterone (DHEA) (systemic lupus erythematosus (SLE), HIV and 
Sjogren’s syndrome). 
• Fluoxetine (HIV, post-stroke and CFS). 
• Amantadine (peripheral neuropathy and MS). 
In terms of aim 2, the magnitude of effect sizes reported by meta-analyses ranged from 0.07 
to 1.23. Anti-TNF biologic agents (for example, adalimumab and infliximab) were 
consistently reported to be effective in reducing fatigue in RA [25,26], IBD [27], and 
sarcoidosis [28]. An effect size of 0.43 was reported for biologics in RA, with similar effects 
for anti-TNFs and non-anti-TNFs [26]. The psychostimulant methylphenidate also showed 
potential benefit across multiple health conditions, including sarcoidosis, PD, TBI and HIV. 
Results for the psychostimulant modafinil were inconsistent. It was reported as potentially 
effective in HIV [29] but findings in MS and TBI were mixed [7, 30-33]. It was reported to 
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be ineffective for PD fatigue [32,34] with a possible trend towards a larger effect in people 
with depression, than those not depressed [35]. 
 
In terms of aim 3, several pharmacological agents were considered in only one or two 
reviews, but were shown to significantly reduce fatigue in the respective condition of interest: 
non-anti-TNFs (RA) [25,26]; thiamine (IBD) [27]; N-acetylcysteine and belimumab (SLE) 
[36]; rasagiline, pergolide mesilate and pramipexole (dopamines) (PD) [35, 37) and prokarin 
(MS) [30].  
 
Pharmacological study limitations 
Reviews highlighted common limitations of pharmacological studies: small sample sizes, 
high risk of bias, variety of outcome measures, fatigue included as a secondary outcome, 
participants not fatigued at baseline, not stating whether change meets minimal clinically 
important difference , short study duration and inadequate statistical analyses. 
 
Non-pharmacological interventions 
Non-pharmacological interventions were considered in 42 reviews, which we grouped into 
exercise, psychological/behavioural and ‘complementary medicine’ interventions (S3-S5 
Tables).  
 
Exercise interventions 
Twenty-nine reviews addressed the effect of exercise on fatigue. These reviews spanned 12 
conditions, as shown in table 3.. Two reviews [38,39] included mixed clinical populations, 
overlapping with single condition reviews. 
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Type and mode of exercise interventions varied considerably, both within and between 
reviews. Across health conditions, most exercise interventions included an aerobic 
component. Mode of exercise typically included cycling, walking, and swimming; however, 
climbing, yoga, dancing and aerobics were also featured. Exercise intensity was mentioned in 
five reviews and was only reported in relation to aerobic exercise. Of the five reviews, two 
were unable to or did not draw conclusions about exercise intensity [7, 40] (both MS), one 
merely reported that exercise intensity in studies ranged from low to high [41] (CFS), one 
reported effective exercise interventions were of moderate intensity [42], (fibromyalgia) and 
one reported that GET appears to be more effective when started at low levels of intensity 
[43](CFS). 
 
Resistance training interventions were reported in reviews in sarcoidosis, HIV, CFS, RA and 
MS, but were the independent focus in only one review in MS [44](Abstract). Most reviews 
did not compare types of exercise, instead including all under the umbrella term ‘exercise’. 
Only two reviews (both MS) compared exercise modalities, concluding that a combination of 
endurance (aerobic) and resistance training may be of most benefit to reduce MS fatigue 
[23,45], mirroring conclusions drawn by Godhrawala et al. [44]. There was considerable 
variation within and across reviews in terms of intervention dose frequency and duration. 
Exercise interventions were reported as typically occurring three times per week, lasting 
approximately 40 minutes and continuing for around 12 weeks. However, this ranged from 
exercising one to seven times per week, for 5-60 minutes and continuing for up to six months.  
 
In terms of the effectiveness of these exercise interventions, addressing aims 2 and 3, effect 
sizes of meta-analyses conducted ranged from 0.36 to 0.68. The considerable variation across 
reviews in different conditions made it difficult to identify specific details of exercise 
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interventions that were effective across conditions. Within individual conditions, findings 
suggest graded exercise therapy (GET) could be effective in ameliorating fatigue in CFS 
[43,46,47]. Physical activity such as yoga, Tai Chi and pool based exercise are reported to be 
beneficial for RA fatigue [12]. Aerobic exercise was the predominant exercise studied in SLE 
patients and was reported to reduce fatigue [36, 48, 49]. Findings presented in the following 
conditions also suggest that exercise may be beneficial in ameliorating fatigue: cardiac 
rehabilitation in coronary heart disease; exercise advice in IBD; aerobic and resistance 
training in sarcoidosis; physical activity such as yoga, walking and pool based exercise in 
fibromyalgia. Reviews also indicate that exercise has an overall moderate effect on fatigue in 
MS. Findings reported in PD, TBI, post-stroke and ESKD reviews suggest exercise may not 
be an effective fatigue intervention. However, one should note that the number and quality of 
studies included in the reviews of PD were limited. 
 
Inconsistencies were reported within reviews as all individual studies did not necessarily find 
exercise interventions to be beneficial. Six reviews highlighted sub-group differences or 
moderators as outlined in Table 4. The sub-groups assessed varied, but factors for 
consideration highlighted by multiple reviews were type of control condition, exercise 
modality, and whether the study sample was fatigued at baseline. 
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Table 4. Reviews reporting exercise intervention subgroup differences 
Study Sub-group 
Marques et al.[47] - CFS Analysis: secondary-tertiary interventions, 
interventions delivered by psychologists or 
psychotherapists and those providing 
minimal contact were more effective 
compared to those in primary care, delivered 
by other healthcare practitioners (e.g. 
exercise/physical therapist, nurse, 
physiologist) and providing intensive contact.  
Including psychological components and 
allowing activity flexibility reported as more 
effective, but with high levels of 
heterogeneity. 
Larun et al. [41] - CFS Analysis: graded aerobic exercise (versus 
treatment as usual) was more effective than 
anaerobic exercise (versus relaxation). 
No differences between diagnostic criteria or 
type of control group. 
Puetz et al. [50] – coronary heart disease Analysis: interventions in non-controlled 
studies were more effective than in controlled 
studies.  
No differences by cardiac rehab intervention 
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type (multifactorial versus exercise). 
Heine et al. [23] – MS Analysis: interventions comparing to non-
exercise controls (versus exercise controls) 
were more effective.  
Intervention type had an effect: endurance 
and mixed training reduced fatigue, whereas 
muscle power and task-orientated training 
did not. 
Andreasen et al. [40] - MS Observation: the majority of studies reporting 
an effect had fatigued population at baseline, 
whereas the majority not reporting an effect 
were those where the study population was 
not.  
No difference by exercise modalities. 
Differing duration, frequency and intensity of 
exercise, and the use of different fatigue 
scales was inconclusive.  
Social interaction and motor mechanisms 
were broached as potential mechanism for 
exercise reducing fatigue. 
Asano et al. [51] – MS Secondary reporting: effect sizes for studies 
including fatigued participants were typically 
positive and significant, whereas for non-
fatigued participants they were negative and 
non-significant. 
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Psychological/behavioural interventions 
Twenty-six reviews addressed the effect of psychological or behavioural interventions on 
fatigue. These reviews spanned twelve conditions, see table 3. Four reviews included mixed 
clinical populations; two reviews combined conditions while investigating general fatigue 
interventions [38,39], while one focused specifically on mindfulness [52] and one on guided 
imagery [53]. 
 
Cognitive behavioural therapy (CBT) was the most cited intervention, referenced in reviews 
of fatigue management in all conditions except IBD, either as a standalone treatment or as a 
basis for treatment,  (e.g. CBT based interventions targeting fluid adherence, sleep or 
physical functioning (ESKD) and cognitive-behavioural stress management (HIV)). Other 
cross-condition intervention techniques included energy conservation (MS and RA), 
expressive writing (RA and SLE), (psycho-)education (SLE, TBI, post-stroke, HIV, MS), 
mindfulness (Post-stroke, TBI, MS – 1 review) and guided imagery (asthma, bronchitis and 
emphysema, cancer, congestive heart failure, MS, HIV – 1 review). Self-management based 
interventions were also common, centring around a variety of topics such as fatigue, stress, 
lifestyle and nutrition (SLE, post-stroke, ESKD, RA, MS, IBD). Finally, other treatment 
modalities reported included ‘relaxation’, ‘solution-focused therapy’, ‘multi-disciplinary 
rehabilitation’, ‘counselling’ and ‘community support’. The use of varying terminology and 
grouping of interventions for overall analysis in reviews must be noted, making accurate 
comparison of individual intervention mechanisms difficult.  
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Referring to aim 2, taken together as a broad category, CBT/behavioural interventions were 
generally reported to be effective in reducing fatigue. Effect sizes reported in meta-analyses 
ranged from 0.24 to 0.48. CBT, psychoeducation, relaxation, counselling, stress management 
and expressive writing were reported as effective in SLE [48,49], although evidence was 
reported as weak and inconsistent by Yuen & Cunningham [36]. Psychosocial interventions, 
including CBT, expressive writing, mindfulness and group education, were reported to reduce 
RA fatigue, but this was a grouped analysis so the differential effects of individual modalities 
was unclear [12]. Again, grouped analyses suggested that psychosocial interventions may be 
beneficial for ESKD fatigue [54]. Relaxation was shown to significantly reduce fatigue in 
HIV, however, cognitive-behavioural stress management/psychoeducation was not [29]. In 
MS, energy conservation and CBT were reported to be effective but long term effects were 
inconsistent [55,56].  
 
Two reviews focussed on a specific type of intervention, as opposed to a health condition. 
Mindfulness was reported to have a significant treatment effect on fatigue compared to no 
treatment or control treatments in post-stroke, TBI and MS [52]. Guided imagery findings 
were more inconsistent, but it was noted that studies demonstrating a significant 
improvement were those that had the greatest total duration of exposure, used targeted 
imagery (based upon condition and outcome) and had over 30 participants [53].  
 
In terms of identifying novel interventions, solution focussed therapy, although only noted in 
one review (IBD), was reported as a promising intervention.  
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Psychological/behavioural interventions varied, for example, in duration of sessions, who 
provided/facilitated the intervention, the length of the intervention, whether it was delivered 
one-to-one or in a group, mode of delivery (e.g. face-to-face, telephone), and intervention 
content. Six reviews addressed sub-group differences (Table 5) suggesting that interventions 
targeting a population fatigued at baseline (compared to non-fatigued) (MS and CFS) and 
one-to-one interventions (ESKD and mixed in mindfulness) may be more effective. Reviews 
in PD, TBI and post-stroke reported that there is little evidence for the effectiveness of 
CBT/behavioural programmes. 
Table 5. Reviews reporting psychological/behavioural intervention subgroup differences 
Study Sub-group 
Castell et al. [43] – CFS Analysis: Interventions with more treatment 
hours were more effective.  
No difference by intervention length, 
treatment settings, format, control group, 
illness duration, diagnostic criteria and study 
quality. 
Malouff et al. [57] – CFS Analysis: correlations between intervention 
effectiveness and hours of treatment, number 
of session, months of follow-up and study 
quality.  
Trend of large effect for physical fatigue and 
small for mental fatigue.  
No difference between subjective and 
objective fatigue. 
Price et al. [58] - CFS Analysis: Interventions conducted 
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individually, compared to treatment as usual 
(versus waiting list) and incorporating 
increased activity were more effective. 
No difference by number of sessions. 
Picariello et al. [54] – ESKD Analysis: Interventions with non-fatigued 
samples at baseline and comparing to active 
controls did not reduce fatigue, whereas 
fatigued samples and comparing to non-
active controls did. Interventions with 
facilitators with lower levels of training were 
more effective.  
Stress management/relaxation based 
interventions were more effective than those 
without. 
No significant difference by CBT based 
interventions or not. 
Wendebourg et al. [59] – MS Analysis: CBT based approaches more 
effective than other techniques (energy 
conservation, multi-disciplinary self-
management, mindfulness).  
Individual approaches more effective than 
group settings. 
Ulrichsen et al. [52] – Mindfulness Observation: Intervention studies using 
fatigue cut-off points and measuring mental 
fatigue reported increased effects. 
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‘Complementary medicine’ interventions 
Fifteen reviews addressed interventions categorised as ‘complementary medicine’ (RA, SLE, 
IBD, MS, TBI, CFS, Post-stroke, ESKD and PD), although one of these did not include any 
papers [22](CFS). Further sub-groups were identified;interventions of Eastern origin (e.g. 
acupuncture, acupuncture based treatment, Chinese herbs, Japanese massage), physiological 
interventions (e.g. cooling, pulsed electro-magnetic devices, phototherapy), diet and 
nutritional supplements (e.g. fish oil, acetyl-carnitine). Interventions included under this 
category in single reviews were reflexology and health tracker information (RA), Qigong 
(CFS) and Tai Chi and Yoga (mixed) (which other reviews considered under physical 
activity), continuous positive airway pressure therapy (post-stroke) and occupational therapy 
(ESKD). 
 
In terms of aim 2, Eastern origin interventions have been investigated in RA (n=1), SLE 
(n=2), CFS (n=1), Post-stroke (n=1), ESKD (n=1) and PD (n=1). These included herbal 
medicine (two reviews; RA and CFS), acupuncture, acupuncture related treatments (e.g. 
minimal needling, electroacupuncture, acupressure, acupoint application) and Japanese 
massage (one review; PD), all of which were reported as effective in reducing fatigue. 
Acupuncture/acupuncture based treatment was the most common intervention, applied and 
reported to be effective across four conditions (all except RA). 
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Diet manipulation was included in reviews in RA and SLE. In both conditions, diet was 
reported to be effective in reducing fatigue, specifically a Mediterranean diet [12](RA), a low 
glycaemic index diet or a low calorie diet [36,48](SLE). Nutritional supplements were 
reported to not reduce fatigue; omega-3 fish oil (IBD and RA), Vitamin D (SLE). Acetyl-L-
carnitine was reported to be more effective for reducing fatigue than amantadine in MS but 
was not compared to an alternative control group [38], overlapping with Tejani et al. [60] in 
pharmacological). 
 
Physiological interventions included: electroencephalographic biofeedback, cranial 
electrotherapy stimulation and bright blue light treatment in TBI [33]; cooling and pulsed 
electromagnetic therapy in MS [7,30]; and UV phototherapy in SLE [36]. Again, all reviews 
reported fatigue reduction. These interventions were more novel, identified as effective in 
individual conditions, addressing aim 3. 
 
Non-pharmacological study limitations 
Reviews highlighted several issues: few studies specifying fatigue as a primary outcome; 
heterogeneous intervention protocols and study designs (e.g. sample sizes, intervention 
length, dose, frequency and session duration); single study findings; heterogeneity in control 
conditions (e.g. waiting list control, active control, treatment as usual); and not considering 
findings in relation to clinically important differences. For ‘complementary medicine’ 
interventions in particular, reviews highlighted that most interventions were only investigated 
by one study, and these studies were often of low quality. This limits the conclusions that can 
be drawn and highlights the need for caution when interpreting the findings. Potential 
publication bias was also noted in this group as most interventions, especially the Chinese 
medicine ones, reported positive findings.  
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Fatigue outcome measures in pharmacological and non-pharmacological 
reviews 
Most reviews (n=44) reported details of fatigue outcome measures, encompassing a large 
number of diverse measures. These ranged from illness specific measures (e.g. PD fatigue 
scale, MS Quality of Life Questionnaire, Kidney Disease Questionnaire), single item Likert-
type scales, subscales of questionnaires (e.g. POMS (vigor/fatigue), SF-36 (vitality)) and 
visual analogue scales, to specific fatigue questionnaires such as Chalder Fatigue Scale, 
Modified Fatigue Impact Scale, Fatigue Severity Scale, Brief Fatigue Inventory and Chronic 
Illness Therapy Fatigue Domain. 
 
Discussion 
We conducted a comprehensive scoping review mapping fatigue interventions in chronic 
health conditions, ranging from those where fatigue is a clearly defined key symptom, such as 
CFS and MS, to less common conditions, such as Sjogren’s syndrome and peripheral 
neuropathy. In the last five years, there has been an increase in the number of published 
reviews. However, we note that interventional studies included in reviews often do not 
specifically target fatigue and include study samples that may not be fatigued at baseline.  
 
Of the pharmacological agents, only anti-TNFs and methylphenidate were identified as 
beneficial across multiple conditions, in line with aim 2. Anti-TNFs were reported to be 
effective treatments for fatigue in RA, IBD, Sjogren’s syndrome and sarcoidosis, all 
conditions classified as autoimmune/inflammatory. Anti-TNF medication acts to suppress the 
response to the tumour necrosis factor (TNF), for example blocking TNFa (a cytokine which 
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stimulates and regulates inflammation and release of other cytokines as part of the 
inflammation cascade) to reduce the inflammatory response [61]. Although this medication is 
targeting inflammatory disease activity as opposed to the fatigue symptom, the cross-
condition benefits indicate fatigue mechanisms may be similar, possibly linked to the body’s 
inflammatory response [62].  
 
In contrast, fluoxetine (an anti-depressant) was reported as ineffective for reducing fatigue in 
HIV [29], post-stroke [63], mixed palliative care population [24] and CFS [46], suggesting 
fatigue in these LTCs is not a symptom of depressed mood [11].  
 
Non-pharmacological interventions were particularly heterogeneous, varying in modality, 
duration and type of intervention provider/facilitator. Even after categorising them into three 
sub-groups (exercise, psychological/behavioural and ‘complementary medicine’), comparison 
was hampered by  intervention heterogeneity. Broadly speaking, aerobic exercise (as well as 
general and mixed exercise models that included a substantial aerobic component) and CBT 
based interventions were the most common and seemed effective in reducing fatigue.  
 
However, none of these were reported to significantly reduce fatigue in three neurological 
conditions: PD, TBI and post-stroke, indicating mechanisms underlying fatigue in these 
conditions may be different. Neurological pathology can cause cognitive difficulties, which 
may account for the ineffectiveness of these interventions in these LTCs [64-66], whereas 
other non-pharmacological interventions, such as cranial electrotherapy stimulation(which do 
not rely on patients’ cognitive abilities), were shown to be effective. Programmes such as 
CBT and graded exercise involve cognitions, planning and goal setting [67]. These may be 
harder to engage in if attentional or memory deficits are present. This is not to say that 
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cognitive impairment makes exercise and CBT interventions ineffective, as physical activity 
has been reported to be beneficial for cognition in a meta-analysis in dementia for example 
[68]. Instead the delivery of these interventions may need  structuring in such a way that is 
accessible for patients.  
Review limitations may also account for inconsistencies: i) reviews included studies which 
had measured fatigue both as a primary (i.e. targeted) outcome or as a secondary outcome; 
and ii) reviews included a range of measures of fatigue, ranging from fatigue-specific 
measures to single item statements. As fatigue was often a secondary outcome, interventions 
may not have been powered to detect changes in fatigue. However, these limitations were not 
confined to reviews in PD, TBI and post-stroke so do not necessarily account for the inter-
condition differences.  
 
Strengths and Limitations 
The in-depth search conducted yielded posters, conference abstracts, protocols, unpublished 
and published articles, and is likely to have captured the relevant research in this area.  
 
However, non-English language papers were not included. Also, of the 64 excluded reviews, 
22 investigated CFS. Although fatigue is the condition-defining symptom, most CFS reviews 
were excluded because they did not specify fatigue as a primary outcome, instead including 
either a range of undefined outcomes or not explicitly stating outcome of interest (see Table 
S6).Cancer-related fatigue was also not included, due to the known association of fatigue 
with the treatment of the condition. Insights and conclusions from reviews in these conditions 
will have been missed. One person undertook screening and extraction. A 10% quality check 
during screening and extraction aimed to minimise the potential of papers or findings being 
missed, but does not negate the risk completely. 
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It is not in the scoping review remit to analyse the quality of reviews or individual studies 
[15], so the review is restrained by reporting; findings for a particular intervention may be 
based on a single or small number of studies of varying quality, as is the case with 
interventions from Eastern origin, for example. This highlights the need to bear in mind the 
aims of the review; to map the current literature and identify patterns, rather than draw 
definite conclusions about the efficacy of a certain intervention. Nonetheless, the quality of 
reviews themselves was also variable: inconsistencies in reporting findings from the same 
studies across reviews arose [34,35,37]; findings were often categorised unclearly and 
inconsistently; some full texts were not received in response to requests; and some reviews 
included studies with a non-RCT design, which may result in high risk of bias. Heterogeneity 
across reviews means it is difficult to assess what the underlying fatigue reduction 
mechanism may be, and subsequently deduce what components would be needed for an 
‘ideal’ fatigue intervention. As per scoping review protocol [15], we did not formally quality 
assess the reviews to rank/ weight the findings we report so conclusions need to be drawn 
cautiously.Our findings narratively describe and map the fatigue intervention literature. Thus, 
only areas of limited research can be identified, which future research could address. Specific 
recommendations for care pathways cannot be made. .  
 
Implications for future research and practice 
Reviewing literature across LTCs highlighted commonalities as well as novel approaches, 
both of which may be potentially useful for developing interventions. As highlighted by 
reviews’ recommendations (S1 Table), the methodological quality of the research in this area 
requires improvement. High quality, guideline adherent RCTs are needed which: recruit 
participants who are fatigued at baseline; trial interventions that specifically target fatigue as 
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a primary outcome; have a well specified theory/hypothesis regarding the mechanisms 
through which intervention reduces fatigue; include long term follow up; and report clinical 
significance.Future reviews should ensure accurate and complete reporting, outline all 
intervention details and analyse moderators where possible. 
In response to aim 2, interventions which may appear most promising for  future 
transdiagnostic research include 1) anti-TNFs and methylphenidate, 2) exercise that is 
substantially aerobic in nature (either when delivered alone or as part of a general or mixed 
exercise approach) and graded, 3) psychologically based approaches including CBT, 
psychoeducation (possibly more so when delivered individually, for increased number of 
hours and, importantly, when specifically targeting fatigue), 4) diet alteration, 5) acupuncture.  
 
Regarding aim 3, more novel, non-pharmacological strategies which may be worth 
considering in other LTCs include solution-focussed therapy, expressive writing and guided 
imagery (if fatigue focussed), and mindfulness.  
 
Although the standard mean differences and their confidence intervals reported in the meta-
analyses suggest treatments were generally more efficacious than control (see Tables S2-S5), 
effect sizes were only small or moderate in size. Therefore, a multifactorial approach 
incorporating multiple strategies (for example, a combined exercise-
psychological/behavioural-acupuncture-diet programme) may be more effective for reducing 
fatigue [69] and[70](RA)..Interventions need to consider different possible underlying fatigue 
mechanisms across different LTCs (e.g. neurological versus inflammatory) so a flexible 
transdiagnostic approach may be needed, taking the pathology and characteristics of the 
patient populations into account [9]. Importantly, several reviews highlighted that 
interventions may need to focus specifically on fatigue in order to elicit the most benefit. 
36 
 
 
Summary 
The aim of a scoping review is to map literature, rather than quality assess or rate evidence, 
so direct recommendations for practice cannot be made [15].Further research into the 
effectiveness, safety and cost of interventions would be needed, as would clear identification 
of mechanisms of action. However, the aims and research questions of this scoping review 
were addressed. Firstly, the evidence reported by systematic reviews on the topic of fatigue 
interventions in LTCs was collated and summarised. Secondly, this highlighted the potential 
transdiagnostic effectiveness of anti-TNFs, methylphenidate, graded aerobic exercise, 
psychological based approaches, diet and acupuncture. Importantly, the pathology of 
conditions may determine effectiveness (for example, whether the condition has an 
autoimmune/inflammatory basis). Lastly, individual condition interventions were identified, 
of which solution focussed therapy, expressive writing, fatigue focussed guided imagery and 
mindfulness may be valuable to explore across other conditions. More work is needed to 
identify transdiagnostic mechanisms of fatigue and to design interventions based on these. 
 
Note 
The following articles were included in the scoping review narrative synthesis but were not 
individually referenced [ 71-78]. 
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Appendix A. Database search strategies 
PsycINFO 6  
1806- Nov week 1 
1. (fatig* adj4 (interven* or improv* or prevent* or program* or therap* or treat* or 
reduc* or manag*)) 
2. Exp “Literature Review”/ or review.mp 
3. ((systematic or quantitative or scoping or narrative or literature) adj4 (review or 
overview or synthesis).mp 
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4. Exp Meta Analysis/ 
5. (meta-analysis or meta analysis or metaanalysis).mp 
6. 2 or 3 or 4 or 5 
7. 1 and 6 
EMBASE 6  
1974-11/11/2016 
1. (fatig* adj4 (interven* or improv* or prevent* or program* or therap* or treat* or 
reduc* or manag*)) 
2. “review”/ 
3. ((systematic or quantitative or scoping or narrative or literature) adj4 (review or 
overview or synthesis).mp 
4. meta analysis/ 
5. (meta-analysis or meta analysis or metaanalysis).mp 
6. 2 or 3 or 4 or 5 
7. 1 and 6 
Ovid MEDLINE(R) 6 
1946 – Nov week 1 2016 
1. (fatig* adj4 (interven* or improv* or prevent* or program* or therap* or treat* or 
reduc* or manag*)) 
2. “Review Literature as Topic”/ or review.mp 
3. ((systematic or quantitative or scoping or narrative or literature) adj4 (review or 
overview or synthesis).mp 
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4. Exp Meta Analysis/ 
5. (meta-analysis or meta analysis or metaanalysis).mp 
6. 2 or 3 or 4 or 5 
7. 1 and 6 
Ovid MEDLINE(R) In process and other non-indexed citations 6  
Until Nov 9th 2016 
1. (fatig* adj4 (interven* or improv* or prevent* or program* or therap* or treat* or 
reduc* or manag*)) 
2. Review.mp or exp “Review”/ 
3. ((systematic or quantitative or scoping or narrative or literature) adj4 (review or 
overview or synthesis).mp 
4. Exp Meta Analysis/ 
5. (meta-analysis or meta analysis or metaanalysis).mp 
6. 2 or 3 or 4 or 5 
7. 1 and 6 
Cochrane 
(-> 18/11/2016) 
N=223 (reviews and protocols) 
N=117 (‘other’ reviews) 
‘fatigue’ 
CINAHL 
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1900 – 2016 present (14/11/2016) 
N=436 
TX ( fatig* N4 (interven* or improv* or prevent* or program* or therap* or treat* or reduc* 
or manag*) ) AND TX ( (systematic or quantitative or scoping or narrative or literature) N4 
(review or overview or synthesis) or meta analysis )  
Web of Science 
All years 
N=485 
TOPIC: (fatig* near/4 (interven* or improv* or prevent* or program* or therap* or treat* or 
reduc* or manag*)) ANDTOPIC: (meta analysis OR ((systematic or quantitative or scoping 
or narrative or literature) NEAR/4 (review or overview or synthesis))) 
 
LILACS 
N=30 
N=3 in English (none of those relevant). 1 is potentially relevant but article in Spanish: 
Efectividad del ejercicio físico en la fatiga de pacientes con cáncer durante el tratamiento 
activo: revisión sistemática y metaanálisis / Effectiveness of physical exercise on fatigue in 
cancer patients during active treatment: a systematic review and meta-analysis / Eficácia do 
exercício físico na fadiga dos pacientes com câncer durante o tratamento ativo: revisão 
sistemática e meta-análise 
53 
 
Meneses-Echávez, Jose Francisco; González-Jiménez, Emilio; Correa-Bautista, Jorge 
Enrique; Valle, Jacqueline Schmidt-Río; Ramírez-Vélez, Robinson. 
Cad Saude Publica; 31(4): 667-681, 04/2015. tab, graf 
Article in Spanish | LILACS | ID: lil-744849 
 
(fatigue) AND (intervention OR improve OR prevent OR program OR therap OR treat OR 
reduc OR manag) AND (review)  
PEDro 
fatig* interven* (Method selected from drop down list =systematic review) 
N=191 
OpenGrey 12/12/16 
“Fatigue [intervention/treatment/management/prevention/therapy/program/improve] Review” 
N=9. None relevant. 
Google  
Consultation suggested to check: 
- Ankylosing spondylitis – 1 – for full text review 
- SLE – 1- (already captured in database search) 
- Polymyositis – 0 
- Vasculitis – 0 
Review Fatigue [Intervention/Treatment] ([condition])  
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New/previously not found: n=3 for full text screening. 

